Bicakcilar is one of the major manufacturers of I.V. cannula in the Middle East and Eastern Europe and is the second largest manufacturer of catheters in Europe.
Bicakcilar exports its products to more than 70 countries.
The products manufactured by Bicakcilar include; infusion, transfusion, respiratory care, catheters, surgical suction, drainage, cardiovascular & custom pack products in disposables, and surgical lights, surgical tables, patient transportation systems and surgical suction devices in medical equipments.
The Global Buyout Fund was advised by Esin Law Firm (legal), Baker & McKenzie (legal), Bionest Partners (industry), PricewaterhouseCoopers (financial), Erdikler (tax) and ELC Group (environmental).
On the other hand, the sellers were advised by Pragma Corporate Finance and YKK (a member of DLA Piper International).
Rajiv Nakani, Managing Partner at Global Capital Management said, "Bicakcilar is one of the most important acquisitions in our portfolio. With its frontier market position, strong and trusted brand, multi-product and multi-channel strategy, and extensive distribution network across Turkey and worldwide, Bicakcilar is ideally positioned to benefit from the rapidly growing healthcare market."
Global Capital Management is an alternative asset management firm that manages five private equity funds, four real estate funds and seven hedge funds with an experienced team of more than 30 professionals based in Kuwait, Dubai, Cairo and Istanbul.
Closed in March 2008, Global Buyout Fund aims to achieve capital appreciation with optimum returns, within controlled levels of risk, over the medium to long term by investing in growth capital in the GCC, Turkey, China and India.
